Incidence and survival of chronic myelomonocytic leukemia in Girona (Spain): a population-based study, 1993-2007.

Abstract

Chronic myelomonocytic leukemia is a very rare blood cancer observed mostly in the elderly. Here we report the incidence trends and survival of patients with chronic myelomonocytic leukemia over a 15-year period (1993-2007). Cases were provided by the population-based Girona Cancer Registry. The crude incidence rate was 0.72/100,000 inhabitants/year. No statistically significant increase in trends was detected over the 15 years. Median overall survival was 28 months although survival markedly decreased with advancing age. The 5-years observed and relative survivals were 20% and 29%, respectively. This is the first population-based study that reports the incidence and survival of chronic myelomonocytic leukemia in Spain.

DOI: 10.1016/j.leukres.2012.06.009

Cite this paper

@article{OscaGelis2012IncidenceAS, title={Incidence and survival of chronic myelomonocytic leukemia in Girona (Spain): a population-based study, 1993-2007.}, author={Gemma Osca-Gelis and Montserrat Puig-Vives and Marc Saez and David Gallardo and Francesc Sol{\'e} and R Marcos-Gragera}, journal={Leukemia research}, year={2012}, volume={36 10}, pages={1262-6} }